Adaptive Biotech
Biotechnology · Health Care

Adaptive Biotech: Funding & valuation

Adaptive Biotech: 2 money records, each linked to its source.

Data updated Nov 20, 2026 · Back to the company report

Financials

Revenue of $277M in 2025. +54.8% on the year before. Net income −$59.5M.

$277MRevenue2025 · +54.8%
−$59.5MNet income2025 · +62.7%
Revenue by yearas filed, with the net income
2025$277Mnet income −$59.5M
2024$179Mnet income −$159.5M
2023$170.3Mnet income −$225.3M
2022$185.3Mnet income −$200.2M
2021$154.3Mnet income −$207.3M
2020$98.4Mnet income −$146.2M
2019$85.1Mnet income −$68.6M
2018$55.7Mnet income −$46.4M
Sources: SEC

Money

Adaptive Biotech: 2 money records, each linked to its source.

$3MCapital expenditureFY2025
From its filingssec.gov ↗
FY2023FY2024FY2025
Capital expenditure$10.7M$3.7M$3M
Stock-based compensation$62.9M$53.6M$51.5M
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".